Atb Cap Markets Weighs in on Organigram FY2024 Earnings

Organigram Holdings Inc. (TSE:OGI) – Research analysts at Atb Cap Markets boosted their FY2024 earnings per share (EPS) estimates for Organigram in a research report issued to clients and investors on Sunday, December 8th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.33) per share for the year, up from their prior forecast of ($0.34). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share.

Separately, Canaccord Genuity Group lowered their target price on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a research note on Monday.

Organigram Stock Down 0.5 %

Shares of OGI opened at C$2.16 on Wednesday. The stock has a 50 day moving average price of C$2.29 and a 200 day moving average price of C$2.31. Organigram has a one year low of C$1.61 and a one year high of C$3.95. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.62 and a current ratio of 6.95. The stock has a market capitalization of C$234.51 million, a price-to-earnings ratio of -0.86, a PEG ratio of 0.42 and a beta of 1.13.

Insider Activity at Organigram

In related news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total transaction of C$30,275.28. Insiders own 31.32% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.